全部股東
股東類型
- 公眾及其他47.65%
- 創投/私募32.30%
- 對沖基金8.70%
- 私人企業6.05%
- 其他5.29%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
OrbiMed Advisors LLC | 10.97% | 688.52 萬 | -- | +688.52 萬 | 25/09/2026 |
Westlake Village BioPartners | 10.11% | 634.75 萬 | -- | +634.75 萬 | 21/09/2026 |
Redmile Group, LLC | 8.70% | 546.29 萬 | -- | +546.29 萬 | 21/09/2026 |
EQT Life Sciences | 6.05% | 379.53 萬 | -- | +379.53 萬 | 21/09/2026 |
Lsp 7 Cooperatief U.A. | 6.05% | 379.53 萬 | -- | +379.53 萬 | 21/09/2026 |
New Leaf Venture Partners, LLC | 5.18% | 324.83 萬 | -- | +324.83 萬 | 18/09/2026 |
Sanofi | 3.92% | 246.19 萬 | -- | +246.19 萬 | 18/09/2026 |
Quehuong DongPresident, CEO & Director | 0.73% | 45.55 萬 | -- | +45.55 萬 | 21/09/2026 |
Nancy StaglianoIndependent Chair | 0.41% | 25.56 萬 | -- | +25.56 萬 | 21/09/2026 |
Graham ParryChief Scientific Officer | 0.14% | 8.55 萬 | -- | +8.55 萬 | 21/09/2026 |
Gary KoeChief Technology Officer | 0.10% | 6.37 萬 | -- | +6.37 萬 | 21/09/2026 |
Matthew FustIndependent Director | 0.00% | 0.00 | -- | +0 | 18/09/2026 |
Kim-Hien DaoChief Medical Officer | 0.00% | 0.00 | -- | +0 | 18/09/2026 |